Literature DB >> 29315598

Improved methods for predicting peptide binding affinity to MHC class II molecules.

Kamilla Kjaergaard Jensen1, Massimo Andreatta2, Paolo Marcatili1, Søren Buus3, Jason A Greenbaum4, Zhen Yan4, Alessandro Sette5,6, Bjoern Peters5,6, Morten Nielsen1,2.   

Abstract

Major histocompatibility complex class II (MHC-II) molecules are expressed on the surface of professional antigen-presenting cells where they display peptides to T helper cells, which orchestrate the onset and outcome of many host immune responses. Understanding which peptides will be presented by the MHC-II molecule is therefore important for understanding the activation of T helper cells and can be used to identify T-cell epitopes. We here present updated versions of two MHC-II-peptide binding affinity prediction methods, NetMHCII and NetMHCIIpan. These were constructed using an extended data set of quantitative MHC-peptide binding affinity data obtained from the Immune Epitope Database covering HLA-DR, HLA-DQ, HLA-DP and H-2 mouse molecules. We show that training with this extended data set improved the performance for peptide binding predictions for both methods. Both methods are publicly available at www.cbs.dtu.dk/services/NetMHCII-2.3 and www.cbs.dtu.dk/services/NetMHCIIpan-3.2.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  MHC binding specificity; T-cell epitope; affinity predictions; immunogenic peptides; peptide-MHC binding

Mesh:

Substances:

Year:  2018        PMID: 29315598      PMCID: PMC6002223          DOI: 10.1111/imm.12889

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  ProPred: prediction of HLA-DR binding sites.

Authors:  H Singh; G P Raghava
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

2.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions.

Authors:  Edita Karosiene; Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Immunogenetics       Date:  2011-10-20       Impact factor: 2.846

Review 3.  MHC class II epitope predictive algorithms.

Authors:  Morten Nielsen; Ole Lund; Søren Buus; Claus Lundegaard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

Review 4.  Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture.

Authors:  F Castellino; G Zhong; R N Germain
Journal:  Hum Immunol       Date:  1997-05       Impact factor: 2.850

5.  TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules.

Authors:  Lianming Zhang; Yiqing Chen; Hau-San Wong; Shuigeng Zhou; Hiroshi Mamitsuka; Shanfeng Zhu
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

6.  Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion.

Authors:  Martin Christen Frølund Thomsen; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2012-05-25       Impact factor: 16.971

7.  SVRMHC prediction server for MHC-binding peptides.

Authors:  Ji Wan; Wen Liu; Qiqi Xu; Yongliang Ren; Darren R Flower; Tongbin Li
Journal:  BMC Bioinformatics       Date:  2006-10-23       Impact factor: 3.169

8.  Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.

Authors:  Hong Huang Lin; Guang Lan Zhang; Songsak Tongchusak; Ellis L Reinherz; Vladimir Brusic
Journal:  BMC Bioinformatics       Date:  2008-12-12       Impact factor: 3.169

9.  Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund
Journal:  BMC Bioinformatics       Date:  2007-07-04       Impact factor: 3.169

10.  The immune epitope database (IEDB) 3.0.

Authors:  Randi Vita; James A Overton; Jason A Greenbaum; Julia Ponomarenko; Jason D Clark; Jason R Cantrell; Daniel K Wheeler; Joseph L Gabbard; Deborah Hix; Alessandro Sette; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

View more
  203 in total

1.  Definition of Naturally Processed Peptides Reveals Convergent Presentation of Autoantigenic Topoisomerase I Epitopes in Scleroderma.

Authors:  Eleni Tiniakou; Andrea Fava; Zsuzsanna H McMahan; Tara Guhr; Robert N O'Meally; Ami A Shah; Fredrick M Wigley; Robert N Cole; Francesco Boin; Erika Darrah
Journal:  Arthritis Rheumatol       Date:  2020-06-26       Impact factor: 10.995

2.  Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning.

Authors:  Derek M Mason; Simon Friedensohn; Cédric R Weber; Christian Jordi; Bastian Wagner; Simon M Meng; Roy A Ehling; Lucia Bonati; Jan Dahinden; Pablo Gainza; Bruno E Correia; Sai T Reddy
Journal:  Nat Biomed Eng       Date:  2021-04-15       Impact factor: 25.671

3.  Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design.

Authors:  Haoyang Zeng; David K Gifford
Journal:  Cell Syst       Date:  2019-06-05       Impact factor: 10.304

4.  Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.

Authors:  Christian Garde; Sri H Ramarathinam; Emma C Jappe; Morten Nielsen; Jens V Kringelum; Thomas Trolle; Anthony W Purcell
Journal:  Immunogenetics       Date:  2019-06-10       Impact factor: 2.846

5.  Identification of antigens presented by MHC for vaccines against tuberculosis.

Authors:  Paulo Bettencourt; Julius Müller; Annalisa Nicastri; Daire Cantillon; Meera Madhavan; Philip D Charles; Carine B Fotso; Rachel Wittenberg; Naomi Bull; Nawamin Pinpathomrat; Simon J Waddell; Elena Stylianou; Adrian V S Hill; Nicola Ternette; Helen McShane
Journal:  NPJ Vaccines       Date:  2020-01-03       Impact factor: 7.344

6.  A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.

Authors:  Daniela P Lage; Patrícia A F Ribeiro; Daniel S Dias; Débora V C Mendonça; Fernanda F Ramos; Lívia M Carvalho; Daysiane de Oliveira; Bethina T Steiner; Vívian T Martins; Luísa Perin; Amanda S Machado; Thaís T O Santos; Grasiele S V Tavares; João A Oliveira-da-Silva; Jamil S Oliveira; Bruno M Roatt; Ricardo A Machado-de-Ávila; Antônio L Teixeira; Maria V Humbert; Eduardo A F Coelho; Myron Christodoulides
Journal:  NPJ Vaccines       Date:  2020-08-13       Impact factor: 7.344

7.  Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products.

Authors:  Wojciech Jankowski; Yara Park; Joseph McGill; Eugene Maraskovsky; Marco Hofmann; Vincent P Diego; Bernadette W Luu; Tom E Howard; Roberta Kellerman; Nigel S Key; Zuben E Sauna
Journal:  Blood Adv       Date:  2019-05-14

8.  TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity.

Authors:  Osman N Yogurtcu; Zuben E Sauna; Joseph R McGill; Million A Tegenge; Hong Yang
Journal:  AAPS J       Date:  2019-08-02       Impact factor: 4.009

9.  New tools for MHC research from machine learning and predictive algorithms to the tumour immunopeptidome.

Authors:  Daniel M Altmann
Journal:  Immunology       Date:  2018-07       Impact factor: 7.397

10.  Poor Antigen Processing of Poxvirus Particles Limits CD4+ T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.

Authors:  Katherine S Forsyth; Brian DeHaven; Mark Mendonca; Sinu Paul; Alessandro Sette; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2019-01-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.